ClinicalTrials.Veeva

Menu

Characterization of Vascular Effects of Angiotensin II in Dorsal Human Hand Veins.

T

Technische Universität Dresden

Status

Completed

Conditions

Healthy Subjects

Treatments

Drug: irbesartan (drug)

Study type

Interventional

Funder types

Other

Identifiers

NCT00180024
IKPD 01-02

Details and patient eligibility

About

The hypothesis is tested that stimulation with angiotensin II after blockade of the AT1-receptor results in venodilation in human healthy subjects in vivo.

Sex

Male

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy subjects

Exclusion criteria

  • any relevant disease

Trial design

Primary purpose

Educational/Counseling/Training

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems